Key Megan D, Andres Douglas A, Der Channing J, Repasky Gretchen A
The Colorado College, Chemistry Department, Colorado Springs, Colorado, USA.
Methods Enzymol. 2006;407:513-27. doi: 10.1016/S0076-6879(05)07041-2.
RERG (Ras-related and estrogen-regulated growth inhibitor), a gene that encodes a small GTP binding and hydrolyzing protein (GTPase) of the Ras superfamily, was originally identified in gene microarray analysis as a gene of which expression is down-regulated in estrogen receptor (ER)-negative breast tumors. Subsequently, RERG mRNA was detected in ER-positive breast tumor-derived cell lines, but not in any of the ER-negative cell lines examined. Furthermore, a comparison of matched tumor and normal tissue samples suggests that RERG expression is lost in kidney, breast, ovary, and colon tumors. The lack of RERG expression in many highly aggressive breast carcinomas suggests that RERG plays an inhibitory role in cell growth and division. In fact, growth of breast tumor cells was inhibited by overexpression of RERG both in vitro and in vivo. In this chapter, we summarize the reagents and approaches used to characterize RERG gene expression, to demonstrate that RERG functions as a GTP/GDP molecular switch, and to characterize the growth inhibitory activity of RERG.
RERG(Ras相关雌激素调节生长抑制因子)是一个编码Ras超家族中小GTP结合和水解蛋白(GTP酶)的基因,最初在基因微阵列分析中被鉴定为一个在雌激素受体(ER)阴性乳腺肿瘤中表达下调的基因。随后,在ER阳性乳腺肿瘤衍生的细胞系中检测到RERG mRNA,但在所检测的任何ER阴性细胞系中均未检测到。此外,对匹配的肿瘤和正常组织样本的比较表明,RERG表达在肾、乳腺、卵巢和结肠肿瘤中缺失。许多高侵袭性乳腺癌中缺乏RERG表达表明RERG在细胞生长和分裂中起抑制作用。事实上,RERG的过表达在体外和体内均抑制了乳腺肿瘤细胞的生长。在本章中,我们总结了用于表征RERG基因表达、证明RERG作为GTP/GDP分子开关发挥作用以及表征RERG生长抑制活性的试剂和方法。